Lung Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Thrombotic microangiopathy with acquired deficiency in ADAMTS 13 activity in lung transplant recipients.

Mal H, Veyradier A, Brugière O, Da Silva D, Colombat M, Azoulay E, Benayoun L, Rondeau E, Dauriat G, Taillé C, Lesèche G, Castier Y, Fournier M

Groupe de Transplantation Pulmonaire, Hôpital Beaujon, Assistance Publique Hx de Paris, Clichy, France. herve.mal@bjn.ap-hop-paris.fr

BACKGROUND: Thrombotic microangiopathy may develop after solid organ transplantation, but it is usually not associated with severe deficiency in von Willebrand factor-cleaving metalloprotease (ADAMTS 13) activity. METHODS: We present the cases of two lung transplant recipients who experienced a thrombotic microangiopathy associated with an acquired severe (<5%) deficiency in ADAMTS 13 activity. RESULTS: A major feature of both cases was the occurrence of a diffuse alveolar hemorrhage. CONCLUSION: Our two cases of lung transplant patients, with thrombotic microangiopathy related to an acquired ADAMTS 13 deficiency recipients, confirm that this mechanism may also be involved in the pathogenesis of thrombotic microangiopathy developing after solid organ transplantation. Therefore, we consider that ADAMTS 13 activity should be assessed on a systematic basis in this setting.

Published 23 June 2006 in Transplantation, 81(12): 1628-32.
Full-text of this article is available online (may require subscription).

© 2005-2008 Lung Transplant Research Today. All Rights Reserved.